Lacticaseibacillus casei
Lacticaseibacillus casei (species-level entry, no specific strain designation) is a broad species grouping that includes well-studied commercial strains such as L. casei Shirota. The papers linked to this entry are heterogeneous, spanning food fermentation, spectroscopic characterization, folate assay methods, and a 2023 RCT examining synbiotic therapy in hospitalized COVID-19 patients. Because the linked evidence does not consistently reference a single strain, and because many papers are methodological rather than clinical, strain-specific health claims cannot be drawn from this record. Species-level properties are not reliably predictive of individual strain behavior.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 1,988 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 684 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
+17 more symptoms
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
6175 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
PMID 41221154 →Lactobacillus casei ’s Antitumor Potential in Colorectal Cancer: Exploring Mechanisms—A Systematic Review· BioMed Research International · 2025
-
[2]
PMID 38954305 →Effect of Lacticaseibacillus casei LC2W Supplementation on Glucose Metabolism and Gut Microbiota in Subjects at High Risk of Metabolic Syndrome: A Randomized, Double-blinded, Placebo-controlled Clinical Trial· Probiotics and Antimicrobial Proteins · 2024
-
[3]
PMID 39485259 →Oral administration of Lactobacillus casei DG® after ileostomy closure in restorative proctocolectomy: a randomized placebo-controlled trial (microbiota and immune microenvironment in pouchitis-MEP1)· Gut Microbes · 2024
-
[4]
PMID 39610194 →Polyphenol‐Scaffolded Modular Assembly of Heterotypic Cell–Cell Assemblies for Potentiating Cancer Immunotherapy· Small · 2024
-
[5]
Source →The effectiveness of the use of synbiotics in the complex therapy of acute intestinal infections in children· Russian Pediatric Journal · 2023
-
[6]
PMID 38205053 →Evaluation of the Probiotic Properties of Lacticaseibacillus casei 431® Isolated from Food for Special Medical Purposes· Food Technology and Biotechnology · 2023
-
[7]
PMID 37604396 →The efficacy of combined arginine and probiotics as an add-on to 1450 ppm fluoride toothpaste to prevent and control dental caries in children – A randomized controlled trial· Journal of Dentistry · 2023
-
[8]
PMID 36856122 →Agave fructans enhance the effects of fermented milk products on obesity biomarkers: a randomised trial· Beneficial Microbes · 2023
-
[9]
PMID 37311176 →Antiobesity Effects of Lactobacillus paracasei Subsp. paracasei, L. casei 431 on High-Fat Diet-Induced Obese Rats· Journal of Medicinal Food · 2023
-
[10]
PMID 37356561 →The effect of a lozenge combining prebiotic arginine and probiotics on caries increment in children during 10–12 months, a randomized clinical trial· Journal of Dentistry · 2023